Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial is a research paper published in The Lancet (2025). On theSindex it has a DataRank of 0.798. It has been cited 31 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0.278
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
Hitachi America Ltd
Grant: 00054494
Massachusetts General Hospital
Grant: U19CA021239
The University of Texas MD Anderson Cancer Center
Grant: P30CA016672
The University of Texas MD Anderson Cancer Center
Grant: R03CA188162
National Institutes of Health
Grant: P01CA285249
NCI NIH HHS
Grant: P01 CA021239
NCI NIH HHS
Grant: P30 CA008748
FWCI
28.52
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords